---
category: news
title: "InterVenn Biosciences Expands Work in Glycoproteomics to Successfully Target a Range of Cancers and Other Indications"
excerpt: "\"InterVenn has developed an artificial intelligence and machine learning -empowered liquid-chromatography- mass ... together with applications from the VennVista suite of solutions for target discovery and validation, therapy response or disease recurrence monitoring, and patient stratification. For more information about InterVenn Biosciences ..."
publishedDateTime: 2020-01-21T16:19:00Z
webUrl: "https://www.tmcnet.com/usubmit/-intervenn-biosciences-expands-work-glycoproteomics-successfully-target-range-/2020/01/21/9084634.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI
  - AI in Healthcare

secured: "sy9PvpGZHglo8SZUVdeY23+nsvxcLJGVIRkn/e0GFV0xIVvjLnRX4IM2FQiqKVeULrxnknPJbas5D+P6HN8+38JtS1dPtagQe3vgxGEBjeAr5nD3DJREneqp/i4qdMzUzbQbsYwa73xrTHtVl4EqFSpHM0Rl7M2kfuqFu/9n32Qnp44KKpHJqtjBhrdVKVPufPyRliX7+VVq2WXSp7RMedVDDe9HuXnN8S1DkgowXF1cuZ0P+igKuOwrE3S/bZIvMI1GyVqjtx2uHGVKfGZ1fd2JwZOPkkW3ZTaMSZKeEJQ=;F2s4KoigQyer9qDovaRplA=="
---

